Tag Archives: endocannabinoids
PM 2 site 207

The effects of cannabinoids on the endocrine system.

Endokrynol Pol. 2018;69(6):705-719. doi: 10.5603/EP.a2018.0072. Borowska M, Czarnywojtek A, Sawicka-Gutaj N, Woliński K1, Płazińska MT, Mikołajczak P, Ruchała M. Author information Abstract Cannabinoids are the derivatives of the cannabis plant, the most potent bioactive component of which is tetrahydrocannabinol (THC). The most commonly used drugs containing cannabinoids are marijuana, hashish, and hashish oil. These compounds […]

Wiley thumbnail

Plants come to mind: Phytocannabinoids, endocannabinoids, and the control of seizures

Editorial – Free Access Jordan S. Farrell Ivan Soltesz First published: 27 December 2018 https://doi.org/10.1111/add.14540 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as […]

PM 2 site 207

Weight loss and improved mood after aerobic exercise training are linked to lower plasma anandamide in healthy people.

Physiol Behav. 2018 Dec 19. pii: S0031-9384(18)30825-4. doi: 10.1016/j.physbeh.2018.12.018. [Epub ahead of print] de Oliveira Belitardo A1, de Mello MT2, Tufik S3, Peres MFP4. Author information Abstract Anandamide, a major endocannabinoid, participates in energy metabolism homeostasis and neurobehavioral processes. In a secondary analyses of an open-label, randomized controlled trial, we investigated the long-term effect of […]

PM 2 site 207

Crosstalk Between Nitric Oxide and Endocannabinoid Signaling Pathways in Normal and Pathological Placentation.

Front Physiol. 2018 Dec 4;9:1699. doi: 10.3389/fphys.2018.01699. eCollection 2018. Abán CE1, Accialini PL2, Etcheverry T2, Leguizamón GF3, Martinez NA4,5, Farina MG2,5. Author information Abstract Endocannabinoids are a group of endogenous lipid mediators that act as ligands of cannabinoid and vanilloid receptors, activating multiple signal transduction pathways. Together with enzymes responsible for their synthesis and degradation, […]

PM 2 site 207

An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers.

Front Behav Neurosci. 2018 Nov 26;12:269. doi: 10.3389/fnbeh.2018.00269. eCollection 2018. Stone NL1, Millar SA1, Herrod PJJ1, Barrett DA2, Ortori CA2, Mellon VA3, O’Sullivan SE1. Author information Abstract The euphoric feeling described after running is, at least in part, due to increased circulating endocannabinoids (eCBs). eCBs are lipid signaling molecules involved in reward, appetite, mood, memory […]

PM 2 site 207

Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression.

Front Mol Neurosci. 2018 Nov 20;11:424. doi: 10.3389/fnmol.2018.00424. eCollection 2018. Stampanoni Bassi M1, Gilio L1,2, Maffei P1, Dolcetti E2, Bruno A2, Buttari F1, Centonze D1,2, Iezzi E1. Author information Abstract The endocannabinoid system (ECS) has been recently recognized as a prominent promoter of the emotional homeostasis, mediating the effects of different environmental signals including rewarding […]

PM 2 site 207

Recent advances in LC-MS/MS methods to determine endocannabinoids in biological samples: Application in neurodegenerative diseases.

Anal Chim Acta. 2018 Dec 31;1044:12-28. doi: 10.1016/j.aca.2018.06.016. Epub 2018 Jun 9. Marchioni C1, de Souza ID2, Acquaro VR Junior2, de Souza Crippa JA3, Tumas V3, Queiroz MEC4. Author information Abstract Endocannabinoids (ECs) are endogenous lipid-based retrograde neurotransmitters that bind to cannabinoid receptors [cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2)]. Many ECs have been […]

PM 2 site 207

Cannabinoids in depressive disorders.

Life Sci. 2018 Oct 2. pii: S0024-3205(18)30604-0. doi: 10.1016/j.lfs.2018.09.058. [Epub ahead of print] Poleszak E1, Wośko S2, Sławińska K2, Szopa A2, Wróbel A3, Serefko A4. Author information Abstract Cannabis sativa is one of the most popular recreational and medicinal plants. Benefits from use of cannabinoid agents in epilepsy, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, and […]

PM 2 site 207

Endocannabinoids, exercise, pain, and a path to health with aging.

Mol Aspects Med. 2018 Oct 2. pii: S0098-2997(18)30035-9. doi: 10.1016/j.mam.2018.10.001. [Epub ahead of print] Watkins BA1. Author information Abstract Physical activity is an important lifestyle factor for growth, development, and sustained health throughout life. In recent years, the benefits of physical activity have drawn more attention to its physiological effects on the body, including well-being. […]

PM 2 site 207

2-arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.

Cardiovasc Res. 2018 Sep 28. doi: 10.1093/cvr/cvy242. [Epub ahead of print] Schloss MJ1, Horckmans M1,2, Guillamat-Prats R1, Hering D1, Lauer E3, Lenglet S3, Weber C1,4,5, Thomas A3,6, Steffens S1,5. Author information Abstract AIMS: Myocardial infarction leads to an enhanced release of endocannabinoids and a massive accumulation of neutrophils and monocytes within the ischemic myocardium. These […]